πŸ‡ΊπŸ‡Έ FDA
Patent

US 11236035

Salts of treprostinil

granted A61PA61P9/12

Quick answer

US patent 11236035 (Salts of treprostinil) held by United Therapeutics Corporation expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P9/12